Recall Register

Food, drugs, devices › GE Healthcare, LLC

Device recall: GE Healthcare, Advantx, Innova 2000, Innova 2100IQ, Innova 3100, Innova 3100IQ, Innova 4100, Innova 4100IQ. Intended for

FDA enforcement event 66254 · Class II · initiated 16 Aug 2013 · status Terminated · terminated 30 May 2014

DeviceVoluntary: Firm initiated1 product recordWaukesha, WI

GE Healthcare, LLC (Waukesha, WI) initiated this device recall on 16 Aug 2013; FDA lists 1 product record under event 66254, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 90% of the 1,236 device enforcement events initiated in 2013 carry the same class.

Status: Terminated, terminated 30 May 2014. Initiation: voluntary: firm initiated. GE Healthcare, LLC has 225 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

GE Healthcare, LLC, Waukesha, WI.

Reason for recall

"GE Healthcare has become aware of a potential safety issue involving missing screws in the overhead Video Monitor Suspension of the Advantx, Innova 2000, Innova 2100IQ, Innova 3100, Innova 3100IQ, Innova 4100, Innova 4100IQ Cardiovascular X-ray imaging systems."

Distribution

"Worldwide Distribution-USA (nationwide) including DC and Puerto Rico, and except ND, SD and VT, and the countries of ALGERIA, ARGENTINA, AUSTRALIA, AUSTRIA, BELARUS, BELGIUM, BOLIVIA, BRAZIL,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0021-2014GE Healthcare, Advantx, Innova 2000, Innova 2100IQ, Innova 3100, Innova 3100IQ, Innova 4100, Innova 4100IQ. Intended for general purpose diagnostic fluoroscopy and radiography studies.2184 (1063 US. 1121 OUS)Class IITerminated23 Oct 2013

Context

90%of 2013 device events are Class II1,236 events that year
1product record in this eventfirm median: 1
225events on this register for the firm

Other enforcement events for GE Healthcare, LLC

InitiatedProduct (first record)TypeClassRecords
27 Feb 2026SIGNA Premier systemsDeviceClass II1
15 Jul 2022(1) GE Centricity Universal Viewer 6.0, Model 2088026-9XX; (2) GE Centricity Universal Viewer 7.0, Model 5826659-0XX; (3DeviceClass II1
24 Jun 2022SIGNA Premier magnetic resonance scanner, model 5748519.DeviceClass II1
14 Jun 2022Centricity PACS Software Version 7.0 SP0.0.4.7DeviceClass II1
8 Jun 2022GE Centricity Universal Viewer Zero Footprint. To view, communicate, process, and display Medical images and data withinDeviceClass II1
2 Jun 2022Service manuals for the CT, PET, or NM table as follows: GT1700/GT1700V/VT1700, GT2000/VT2000, GT2000x/VT2000x, High CapDeviceClass II1
1 Jun 2022GE Healthcare Aisys CS2 Anesthesia System, Part number 1011-9050-000; and Avance CS2 and Avance CS2 Pro Anesthesia SysteDeviceClass I1
27 May 2022GE Healthcare Avance CS2, Avance CS2 Pro Anesthesia Systems, Part #1009-9050-000; and Aisys CS2 Anesthesia Systems, PartDeviceClass II1
10 May 2022CARESCAPE Central Station (CSCS) V2, Model numbers 2082278-001 and 2082279-001. Update 3/10/2023: The following FRU and DeviceClass II1
28 Apr 2022Centricity Universal Viewer Zero Footprint ClientDeviceClass II5

All 225 events for GE Healthcare, LLC

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "GE Healthcare has become aware of a potential safety issue involving missing screws in the overhead Video Monitor Suspension of the Advantx, Innova 2000, Innova 2100IQ, Innova 3100, Innova 3100IQ, Innova 4100, Innova 4100IQ Cardiovascular X-ray imaging systems."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution-USA (nationwide) including DC and Puerto Rico, and except ND, SD and VT, and the countries of ALGERIA, ARGENTINA, AUSTRALIA, AUSTRIA, BELARUS, BELGIUM, BOLIVIA, BRAZIL,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 30 May 2014. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.